Home / PPLPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PPLPHARMA.NS make money? Does PPLPHARMA.NS have pricing power? What's the Earnings Whisper? Will PPLPHARMA.NS profit more as the business scales? What is PPLPHARMA.NS's management track record? Is PPLPHARMA.NS's current price justified?

Piramal Pharma Limited

₹197.73 +$27.85 (+16.39%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹194.43

Day Range

₹193.6₹198.75

Year Range

₹132.3₹231.93

Market Cap

262B

AVG Volume

6.41M

Trailing/Forward PE

-83.43/52.43

PEG ratio

0.35

Dividend Yield

Next Earnings Date

2026-11-11

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

PPLPHARMA.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	92.05B
26 Q4	88.69B
26 Q3	87.81B
26 Q2	88.46B
26 Q1	90.44B
25 Q4	90.61B
25 Q3	88.85B
25 Q2	86.39B
25 Q1	83.09B
24 Q4	81.06B

Net Income (INR) · TTM

PPLPHARMA.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	-3.14B
26 Q4	-3.26B
26 Q3	-1.64B
26 Q2	-237.4M
26 Q1	980.7M
25 Q4	911.3M
25 Q3	389M
25 Q2	453.3M
25 Q1	277.6M
24 Q4	178.2M

Operating Income (INR) · TTM

PPLPHARMA.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	1.53B
26 Q4	903.9M
26 Q3	2.17B
26 Q2	3.75B
26 Q1	5.68B
25 Q4	6.79B
25 Q3	6.2B
25 Q2	5.61B
25 Q1	4.93B
24 Q4	4.32B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Piramal Pharma Limited

Video analysis: PPLPHARMA.NS

News: PPLPHARMA.NS

Similar companies